Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Osteopathia striata-pigmentary dermopathy-white forelock syndrome is characterized by the association of osteopathia striata (longitudinal striations through most of the long bones) with a macular, hyperpigmented dermopathy and a white forelock.
Features include very common findings: Abnormal diaphysis morphology, Abnormal metaphysis morphology, White forelock, and Abnormal pelvic girdle bone morphology and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 2 | Abnormal pelvic girdle bone morphology, Osteopathia striata |
Biomarker and diagnostic research for osteopathia striata-pigmentary dermopathy-white forelock syndrome has been reported in the published literature.
Phenotype severity distribution: 7 very common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for osteopathia striata-pigmentary dermopathy-white forelock syndrome.
129 publications have been identified in PubMed for osteopathia striata-pigmentary dermopathy-white forelock syndrome. Research spans Review / Meta-Analysis (69%), Basic Science / Preclinical (14%), and Epidemiology / Natural History (7%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 89 | 69% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 6:26 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Macular hyperpigmented dermopathy |
Skin | 1 | Macular hyperpigmented dermopathy |
Laboratory research |
18 |
14% |
Disease patterns and progression | 9 | 7% |
Patient case studies | 6 | 5% |
Other research | 4 | 3% |
Testing and diagnosis research | 3 | 2% |
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Buel KL (2026). [PMID: 41569909](https://pubmed.ncbi.nlm.nih.gov/41569909/). *FP Essent*. [Review / Meta-Analysis]
Serpieri V (2026). [PMID: 41720098](https://pubmed.ncbi.nlm.nih.gov/41720098/). *Am J Hum Genet*. [Basic Science / Preclinical]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
He C (2025). [PMID: 40249538](https://pubmed.ncbi.nlm.nih.gov/40249538/). *Aging Clin Exp Res*. [Epidemiology / Natural History]
Garcia-Diez AI (2025). [PMID: 40610162](https://pubmed.ncbi.nlm.nih.gov/40610162/). *Magn Reson Imaging Clin N Am*. [Review / Meta-Analysis]
Van't Hoff C (2025). [PMID: 41308001](https://pubmed.ncbi.nlm.nih.gov/41308001/). *J Frailty Aging*. [Review / Meta-Analysis]
Kaul A (2025). [PMID: 40915300](https://pubmed.ncbi.nlm.nih.gov/40915300/). *Lancet Rheumatol*. [Review / Meta-Analysis]